Clinical Characteristics, Management, and Outcomes of Japanese Patients Hospitalized for Heart Failure With Preserved Ejection Fraction - A Report From the Japanese Heart Failure Syndrome With Preserved Ejection Fraction (JASPER) Registry

Circ J. 2018 May 25;82(6):1534-1545. doi: 10.1253/circj.CJ-18-0073. Epub 2018 Mar 23.

Abstract

Background: Despite the specific characteristics of heart failure with preserved ejection fraction (HFpEF) having been demonstrated predominantly from registries in Western countries, important international differences exist in terms of patient characteristics, management and medical infrastructure between Western and Asian countries.Methods and Results:We performed nationwide registration of consecutive Japanese hospitalized HFpEF patients with left ventricular EF ≥50% from 15 sites between November 2012 and March 2015. Follow-up data were obtained up to 2 years post-discharge. A total of 535 patients were registered. The median age was 80 years and 50% were female. The most common comorbid conditions were hypertension (77%) and atrial fibrillation (AF: 62%), but body mass index was relatively low. In-hospital mortality rate was 1.3% and the median length of hospitalization was 16 days. By 2 years post-discharge, 40.8% of patients had all-cause death or HF hospitalization. Approximately one-half of deaths had a cardiac cause. Lower serum albumin on admission was one of the strongest independent determinants of worse clinical outcome.

Conclusions: Japanese HFpEF patients were less obese, but had a substantially higher prevalence of AF and lower incidence of subsequent events compared with previous reports. Our findings indicated that specific preventative and therapeutic strategies focusing on AF and nutritional status might need to be considered for Japanese hospitalized patients with HFpEF.

Keywords: Albumin; Epidemiology; Heart failure with preserved ejection fraction; Japan; Prognosis.

Publication types

  • Multicenter Study

MeSH terms

  • Aged
  • Aged, 80 and over
  • Atrial Fibrillation / epidemiology*
  • Body Mass Index
  • Cause of Death
  • Disease Management
  • Female
  • Follow-Up Studies
  • Heart Failure / complications
  • Heart Failure / epidemiology*
  • Heart Failure / mortality
  • Heart Failure / therapy
  • Hospital Mortality
  • Hospitalization
  • Humans
  • Japan
  • Length of Stay
  • Male
  • Prevalence
  • Prognosis
  • Registries
  • Serum Albumin / analysis
  • Stroke Volume*
  • Treatment Outcome

Substances

  • Serum Albumin